Gastric mucosal protection against ethanol by EP2 and EP4 signaling through the inhibition of leukotriene C4 production.

Prostaglandin (PG)E derivatives are widely used for treating gastric mucosal injury. PGE receptors are classified into four subtypes, EP(1), EP(2), EP(3), and EP(4). We have tested which EP receptor subtypes participate in gastric mucosal protection against ethanol-induced gastric mucosal injury and clarified the mechanisms of such protection. The gastric mucosa of anesthetized rats was perfused at 2 ml/min with physiological saline, agonists for EP(1), EP(2), EP(3), and EP(4), or 50% ethanol, using a constant-rate pump connected to a cannula placed in the esophagus. The gastric microcirculation of the mucosal base of anesthetized rats was observed by transillumination through a window made by removal of the adventitia and muscularis externa. PGE(2) and subtype-specific EP agonists were applied to the muscularis mucosae at the window. Application of 50% ethanol dilated the mucosal arterioles and constricted the collecting venules. Collecting venule constriction by ethanol was completely inhibited by PGE(2) and by EP(2) and EP(4) agonists (100 nM) but not by an EP(1) or an EP(3) agonist. Ethanol-induced mucosal injury was also inhibited by EP(2) and EP(4) agonists. When leukotriene (LT)C(4) levels in the perfusate of the gastric mucosa were determined by ELISA, intragastric ethanol administration elevated the LTC(4) levels sixfold from the basal levels. These elevated levels were significantly (60%) reduced by both EP(2) and EP(4) agonists but not by other EP agonists. Since LTC(4) application at the window constricted collecting venules strongly, and an LTC antagonist reduced ethanol-induced mucosal injury, reductions in LTC(4) generation in response to EP(2) and EP(4) receptor signaling may be relevant to the protective action of PGE(2). The present results indicate that EP(2) and EP(4) receptor signaling inhibits ethanol-induced gastric mucosal injury through cancellation of collecting venule constriction by reducing LTC(4) production.

[1]  M. Mulholland,et al.  Current concepts in the pathophysiology and treatment of portal hypertension and variceal hemorrhage , 1991, Gastroenterologia Japonica.

[2]  Y. Nawa,et al.  The possible role of LTC4 in the pathogenesis of ethanol-induced gastric lesions in mice and their prevention by 5-lipoxygenase inhibitor AA-861, and leukotriene receptor antagonist FPL-55712 , 1991, Gastroenterologia Japonica.

[3]  K. Saigenji,et al.  Direct observation of microcirculation of the basal region of rat gastric mucosa , 1995, Journal of Gastroenterology.

[4]  S. Szabó,et al.  Vascular injury in acute gastric mucosal damage , 1988, Digestive Diseases and Sciences.

[5]  P. Guth,et al.  In vivo microscopy of the gastric microcirculation , 1972, The American Journal of Digestive Diseases.

[6]  Ph.D. André Robert M.D.,et al.  Inhibition of gastric secretion by prostaglandins , 2005, The American Journal of Digestive Diseases.

[7]  M. Suematsu,et al.  Role of thromboxane derived from COX‐1 and ‐2 in hepatic microcirculatory dysfunction during endotoxemia in mice , 2004, Hepatology.

[8]  E. Goetzl.  Mast cell-mediated reactions of host defense and tissue injury , 1977, Inflammation.

[9]  K. Saigenji,et al.  Mild irritant prevents ethanol-induced gastric mucosal microcirculatory disturbances through actions of calcitonin gene-related peptide and PGI2 in rats. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[10]  M. Majima,et al.  Prostanoid receptor signaling relevant to tumor growth and angiogenesis. , 2003, Trends in pharmacological sciences.

[11]  N. Hatae.  [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype]. , 2003, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[12]  S. Narumiya,et al.  Endogenous prostaglandin I2 regulates the neural emergency system through release of calcitonin gene related peptide , 2003, Gut.

[13]  T. Tsuchiya,et al.  Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation* , 2003, The Journal of Biological Chemistry.

[14]  S. Anant,et al.  Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[15]  Yukihiko Sugimoto,et al.  Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003, The Journal of experimental medicine.

[16]  T. Tsuchiya,et al.  Prostaglandin E 2 Protects Gastric Mucosal Cells from Apoptosis via EP 2 and EP 4 Receptor Activation * , 2003 .

[17]  Yukihiko Sugimoto,et al.  Host Prostaglandin E 2-EP 3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003 .

[18]  M. Katori,et al.  Transient prevention of ethanol-induced gastric lesion by capsaicin due to release of endogenous calcitonin gene-related peptide in rats. , 2001, Japanese journal of pharmacology.

[19]  S. Narumiya,et al.  Adaptive cytoprotection mediated by prostaglandin I(2) is attributable to sensitization of CRGP-containing sensory nerves. , 2001, Gastroenterology.

[20]  S. Narumiya,et al.  The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. , 2000, Endocrinology.

[21]  S. Narumiya,et al.  Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.

[22]  K. Takeuchi,et al.  The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach , 2000, Alimentary pharmacology & therapeutics.

[23]  K. Saigenji,et al.  Mechanism of prevention by capsaicin of ethanol‐induced gastric mucosal injury – a study in the rat using intravital microscopy , 2000, Alimentary pharmacology & therapeutics.

[24]  須澤 徹夫.  The role of prostaglandin E receptor Subtypes(EP1,EP2,EP3 and EP4)in bone resorption : An analysis using Specific agonists for the Respective EPs , 2000 .

[25]  S. Narumiya,et al.  Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. , 1999, Cancer research.

[26]  S. Narumiya,et al.  Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[28]  Atsushi Ichikawa,et al.  Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 , 1998, Nature.

[29]  K. Takeuchi,et al.  Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. , 1997, Gastroenterology.

[30]  S. Narumiya,et al.  Altered pain perception and inflammatory response in mice lacking prostacyclin receptor , 1997, Nature.

[31]  S. Narumiya,et al.  Failure of parturition in mice lacking the prostaglandin F receptor. , 1997, Science.

[32]  T. Chiba,et al.  Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. , 1997, The American journal of physiology.

[33]  Y. Okuma,et al.  Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane‐anaesthetized rats , 1996, British journal of pharmacology.

[34]  H. Matsui,et al.  Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line. , 1996, Digestion.

[35]  T. Chiba,et al.  Copresence of prostaglandin EP2 and EP3 receptors on gastric enterochromaffin-like cell carcinoid in African rodents. , 1995, Gastroenterology.

[36]  R. DuBois,et al.  Eicosanoids and the gastrointestinal tract. , 1995, Gastroenterology.

[37]  S. Narumiya,et al.  Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype , 1995, FEBS letters.

[38]  K. Saigenji,et al.  Different responses of arterioles and venules in rat gastric mucosal microcirculation to endothelin-1 and endothelin-3. , 1995, Journal of clinical gastroenterology.

[39]  R. A. Coleman,et al.  A novel inhibitory prostanoid receptor in piglet saphenous vein. , 1994, Prostaglandins.

[40]  S. Ito,et al.  Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. , 1993, The Journal of biological chemistry.

[41]  M. Katori,et al.  An important role of leukotriene C4 in microcirculation during ethanol-induced gastric mucosal injury in rat. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[42]  J. Wallace,et al.  Reduction of ethanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins, and mast cells in the protective mechanism. , 1989, Canadian journal of physiology and pharmacology.

[43]  H. Wayland,et al.  Role of arachidonic acid metabolites in ethanol vasoaction in rat gastric submucosa. , 1988, The American journal of physiology.

[44]  A. Tarnawski,et al.  Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin. , 1988, The Journal of clinical investigation.

[45]  M. Katori,et al.  Release of endogenous prostaglandins by mild hyperosmotic saline inhibits tetragastrin-stimulated gastric acid secretion in rats. , 1986, Prostaglandins.

[46]  B. Peskar,et al.  Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa. , 1986, Prostaglandins.

[47]  S. Peters,et al.  Isolation and characterization of human intestinal mucosal mast cells. , 1985, Journal of immunology.

[48]  P. Guth,et al.  Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. , 1984, Gastroenterology.

[49]  K. Austen.  The heterogeneity of mast cell populations and products. , 1984, Hospital practice.

[50]  Kay Ab.  Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. , 1983 .

[51]  A. B. Kay.  Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. , 1983, European journal of respiratory diseases. Supplement.

[52]  G. Kauffman,et al.  Gastric gel mucus thickness: effect of distention, 16,16-dimethyl prostaglandin e2, and carbenoxolone. , 1981, Gastroenterology.

[53]  A. Robert,et al.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. , 1979, Gastroenterology.

[54]  W. Beaumont.  Nutrition Classics. Experiments and observations on the gastric juice and the physiology of digestion. By William Beaumont. Plattsburgh. Printed by F. P. Allen. 1833. , 1977, Nutrition reviews.